Published in Hepatology on February 01, 2000
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis (2008) 1.39
Hepatic venous outflow obstruction: three similar syndromes. World J Gastroenterol (2007) 1.29
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. J Hepatol (2013) 1.20
Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. Gastroenterology (2009) 1.16
The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome. Br J Cancer (2013) 1.02
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes. Biol Blood Marrow Transplant (2013) 0.90
Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer. Br J Cancer (2013) 0.82
Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol (2007) 0.80
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning. Ther Drug Monit (2015) 0.75
Histological, molecular and biochemical detection of renal injury after Echis pyramidum snake envenomation in rats. Saudi J Biol Sci (2014) 0.75
Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice. Acta Pharmacol Sin (2013) 0.75
Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70
Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am J Med (1996) 1.62
Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis (1989) 1.50
Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology (1999) 1.29
Peliosis hepatis in a patient with human immunodeficiency virus infection. AJR Am J Roentgenol (1991) 1.23
Survival in patients with postnecrotic cirrhosis and Laennec's cirrhosis undergoing therapeutic portacaval shunt. Gastroenterology (1977) 1.06
Delta agent superinfection. Rapidly progressive liver disease in a hepatitis B virus carrier. Arch Pathol Lab Med (1985) 0.96
Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome. Hepatology (1985) 0.88
Ultrasonographic diagnosis of acute alcoholic hepatitis 'pseudoparallel channel sign' of intrahepatic artery dilatation. Gastroenterology (1993) 0.88
Glomerular tubular reflux--a morphologic renal lesion associated with the hepatorenal syndrome. Hepatology (1984) 0.87
A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol (1980) 0.84
High-density lipoprotein cholesterol and liver disease. Hepatology (1983) 0.84
Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology (1994) 0.83
Sex and strain differences in response to cocaine. Biochem Pharmacol (1984) 0.81
Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence. Dig Dis Sci (1991) 0.80
Enzyme changes and morphometric analysis of bile ducts in experimental bile duct obstruction. Clin Chim Acta (1979) 0.80
Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med (1984) 0.78
Globular hepatic amyloid--an unusual morphologic presentation. Hepatology (1982) 0.78
Acetaminophen, isoniazid, and hepatic toxicity. Ann Intern Med (1991) 0.78
Hepatorenal syndrome without avid sodium retention. Hepatology (1986) 0.76
Osteomyelitis associated with pressure ulcers. Arch Phys Med Rehabil (1986) 0.76
Fulminant hepatic and renal failure complicating Wilson's disease. Liver (1984) 0.75
"Naturally-occurring" anti-K1: possible association with mycobacterium infection. Transfusion (1978) 0.75
Atypical diffuse angiosarcoma of the liver. West J Med (1987) 0.75
Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study. Biomed Pharmacother (1989) 0.75
Liver damage from narcotics in mice. Toxicol Appl Pharmacol (1981) 0.75
Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals. Dig Dis Sci (1986) 0.75
Control of ventilation, respiratory muscle strength, and granulomatous involvement of skeletal muscle in patients with sarcoidosis. Chest (1993) 0.75
Plasma concentration-response relationships of two formulations of propranolol. J Clin Pharmacol (1985) 0.75
Heart failure and the liver. Gastroenterology (1978) 0.75
Fatal intrathoracic hemorrhage in a patient with von Recklinghausen's disease. Respiration (1995) 0.75